๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Theoretical analysis of the regulation of interferon expression during priming and blocking

โœ Scribed by S.I. Bazhan; V.A. Likhoshvai; O.E. Belova


Book ID
102975735
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
591 KB
Volume
175
Category
Article
ISSN
0022-5193

No coin nor oath required. For personal study only.

โœฆ Synopsis


Interferon superinduction, in the case of cell pretreatment with low doses of interferon (priming), may be explained by activation of 2',5'-oligoadenylate synthetase and endonuclease L, since the latter, as expected, leads to a more rapid amplification of the standard scheme of interferon induction based on the antirepression mechanism. In the given case, endonuclease L will further increase the degradation rates for messages, which encode repressor proteins controlling interferon gene expression. Under ordinary induction, these messages are destroyed only by short-lived nuclease activated by double-stranded RNA. Cell pretreatment with high doses of interferon (blocking) considerably increases the concentrations of protein kinase and 2',5'-oligoadenylate synthetase in the cell. However, it seems that during blocking protein kinase plays the main role in inhibition of interferon synthesis, and this leads to almost complete depression of translation in the cell. When protein kinase is not sufficiently activated, blocking does not occur since treatment of cells with high concentrations of interferon does not hinder priming induced by 2',5'-oligoadenylate synthetase and endonuclease L. The proposed model is consistent with the findings that both interferon-treated primed and blocked cells are able to produce interferon more rapidly than normal cells. The analysis, based on a computer simulation model, suggests that priming and blocking of interferon may be based on processes controlling its induction and antiviral activity.


๐Ÿ“œ SIMILAR VOLUMES


Interferon receptor expression regulates
โœ T. Charis Wagner; Sharlene Velichko; Steven K. Chesney; Sandra Biroc; Dean Harde ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 443 KB

## Abstract In addition to antiviral effects, Type I interferons (IFN) have potent antiproliferative and immunomodulatory activities. Because of these properties IFNs have been evaluated as therapeutics for the treatment of a number of human diseases, including cancer. Currently, IFNs have been sho